EP2231622A4 - Preparations containing amino acids and orotic acid - Google Patents

Preparations containing amino acids and orotic acid

Info

Publication number
EP2231622A4
EP2231622A4 EP07855591A EP07855591A EP2231622A4 EP 2231622 A4 EP2231622 A4 EP 2231622A4 EP 07855591 A EP07855591 A EP 07855591A EP 07855591 A EP07855591 A EP 07855591A EP 2231622 A4 EP2231622 A4 EP 2231622A4
Authority
EP
European Patent Office
Prior art keywords
amino acids
containing amino
preparations containing
orotic acid
orotic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP07855591A
Other languages
German (de)
French (fr)
Other versions
EP2231622A1 (en
Inventor
Joseph Macdougall
Shan Chaudhuri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northern Innovations and Formulations Corp
Original Assignee
Northern Innovations and Formulations Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Northern Innovations and Formulations Corp filed Critical Northern Innovations and Formulations Corp
Publication of EP2231622A1 publication Critical patent/EP2231622A1/en
Publication of EP2231622A4 publication Critical patent/EP2231622A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
EP07855591A 2007-12-18 2007-12-18 Preparations containing amino acids and orotic acid Withdrawn EP2231622A4 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CA2007/002309 WO2009076743A1 (en) 2007-12-18 2007-12-18 Preparations containing amino acids and orotic acid

Publications (2)

Publication Number Publication Date
EP2231622A1 EP2231622A1 (en) 2010-09-29
EP2231622A4 true EP2231622A4 (en) 2011-01-19

Family

ID=40795135

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07855591A Withdrawn EP2231622A4 (en) 2007-12-18 2007-12-18 Preparations containing amino acids and orotic acid

Country Status (2)

Country Link
EP (1) EP2231622A4 (en)
WO (1) WO2009076743A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105294575A (en) * 2015-12-03 2016-02-03 常州工程职业技术学院 Preparation method of methyl orotate
WO2018012157A1 (en) 2016-07-14 2018-01-18 昭和電工株式会社 Melanin production inhibitor, skin-lightening agent, fibroblast cell activator, collagen and/or elastin production promotor, and wrinkle-improving agent
WO2020100712A1 (en) 2018-11-12 2020-05-22 昭和電工株式会社 Method for producing orotic acid derivative

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2015452A1 (en) * 1969-04-04 1971-04-01 Les Lts C David Rabot, Courbevoie, Hauts de Seine (Frankreich) Amidosauren, Amidosauresalze and drugs and processes formed therefrom for the production of these substances

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1980M (en) * 1962-05-21 1963-08-26 Aec Chim Organ Biolog Reconstructive drug, regenerator of hepatic and galactogenic tissues based on an amino acid orotate.
RU2086543C1 (en) * 1995-10-16 1997-08-10 Всероссийский научный центр по безопасности биологически активных веществ Alkaline salts of amides of orotic acid and amino acids, having hypertensive action
US6838562B2 (en) * 2003-04-01 2005-01-04 Sal Abraham Process for preparing a creatine heterocyclic acid salt and method of use
US20050250674A1 (en) * 2004-10-21 2005-11-10 Daniel Amato Nutritional and food supplement preparation comprising creatine and orotic acid complexes, derivatives and analogs

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2015452A1 (en) * 1969-04-04 1971-04-01 Les Lts C David Rabot, Courbevoie, Hauts de Seine (Frankreich) Amidosauren, Amidosauresalze and drugs and processes formed therefrom for the production of these substances

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2009076743A1 *

Also Published As

Publication number Publication date
EP2231622A1 (en) 2010-09-29
WO2009076743A1 (en) 2009-06-25

Similar Documents

Publication Publication Date Title
HRP20181823T1 (en) Amino acid lipids and uses thereof
EP2197897A4 (en) Amino acid pairing-based self assembling peptides and methods
HK1134029A1 (en) Amino acid composition
EP2225275A4 (en) Protein formulation
EP2173377A4 (en) Antibody-endostatin fusion protein and its variants
HK1189027A1 (en) Highly pure plasmid dna preparations and processes for preparing the same dna
ZA201003681B (en) Compositions and methods comprising basic amino acid peptides and proteases
HK1131557A1 (en) Glyceryl and glycol acid compounds
EP2234636A4 (en) Stabilized formulations of peptides and proteins
IL193700A0 (en) Medicaments and proteins
GB0615635D0 (en) Immunogenic proteins and uses thereof
HK1116417A1 (en) Amino acid derivatives
EP2239267A4 (en) Tag peptide and use thereof
HK1142278A1 (en) Nucleic acid complex and nucleic acid delivery composition
EP2280024A4 (en) Polypeptide specifically coupled to phosphatidylserine and use thereof
GB0713189D0 (en) Amino acid derivatives
EP2231622A4 (en) Preparations containing amino acids and orotic acid
GB0602780D0 (en) Amino Acid Derivatives
HK1161280A1 (en) Peptide having anti-diabetic activity and use thereof
IL206334A0 (en) Sarp-i fusion proteins and their use
GB0715712D0 (en) Amino acid derivatives
GB0625671D0 (en) Protein formulation
EP2275437A4 (en) Polypeptide and pharmaceutical composition containing the polypeptide
GB0823550D0 (en) Peptide tag and uses thereof
GB0724832D0 (en) Proteins and nucleic acids

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100716

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: CHAUDHURI, SHAN

Inventor name: MACDOUGALL, JOSEPH

A4 Supplementary search report drawn up and despatched

Effective date: 20101220

DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20110727